Treatment of Staphylococcus aureus in Urine
Initial Assessment and Risk Stratification
- Asymptomatic bacteriuria should not be treated in most patients, as it typically represents contamination or colonization that does not warrant antimicrobial therapy, according to the American College of Physicians 1
- Symptomatic UTI with properly collected urine culture showing ≥50,000 CFU/mL of S. aureus as a single pathogen requires treatment, as recommended by the Infectious Diseases Society of America 1
When Treatment IS Indicated
- Targeted antimicrobial therapy based on susceptibility testing should be used for symptomatic UTI with confirmed S. aureus, with options including cefazolin or antistaphylococcal penicillins for MSSA, and vancomycin or daptomycin for MRSA, as suggested by the American College of Physicians 1
- Alternative therapy for MSSA if penicillin allergy includes ciprofloxacin or clindamycin, according to the American College of Physicians 1
- Duration of therapy is 7 days for prompt symptom resolution and 10-14 days for delayed response, as recommended by the Infectious Diseases Society of America 1
Catheter-Associated S. aureus Bacteriuria
- The catheter should be replaced if it has been in place ≥2 weeks before starting antimicrobial therapy, as antibiotic therapy alone will likely fail due to biofilm formation, according to the Centers for Disease Control and Prevention 1
Pre-Procedure Prophylaxis
- Asymptomatic S. aureus bacteriuria should be screened for and treated only before endoscopic urologic procedures with mucosal trauma, using 1-2 doses of targeted antimicrobial administered 30-60 minutes before the procedure, as recommended by the American Urological Association 1
When S. aureus Bacteremia is Confirmed
- Transesophageal echocardiography is recommended for high-risk patients with S. aureus bacteremia, including those with persistent bacteremia ≥48 hours, persistent fever, metastatic infection foci, or implantable cardiac devices, according to the Infectious Diseases Society of America 2
- Duration of therapy for S. aureus bacteremia is minimum 14 days if uncomplicated and 4-6 weeks if complicated or endocarditis is present, as recommended by the Infectious Diseases Society of America 2
Monitoring and Follow-Up
- Clinical response should be assessed within 48-72 hours and antibiotics adjusted based on culture and susceptibility results, as recommended by the American College of Physicians 1